Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

1,015.61

904.43

895.22

1,083.79

793.68

Operating profit

98.83

-66.56

21.48

55.15

49.59

Interest

76.70

60.68

38.15

36.09

30.19

Gross profit

56.12

-99.30

75.66

50.22

73.26

EPS (Rs)

1.03

-7.78

20.37

-0.30

1.99

Other income

33.99

27.94

92.33

31.16

53.86

Stock adjustment

7.12

0.30

42.59

71.66

26.13

Raw material

504.04

578.98

475.71

459.72

395.73

Power and fuel

-

-

-

-

-

Employee expenses

162.95

137.54

121.01

151.08

129.90

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

242.67

254.17

234.43

346.17

192.33

Provisions made

-

-

-

-

-

Depreciation

42.80

48.65

50.64

53.73

47.92

Taxation

4.04

-77.70

-157.88

-0.80

7.50

Net profit / loss

9.29

-70.25

182.90

-2.71

17.84

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

90.30

90.29

89.79

89.78

89.63

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

9.73

-7.36

2.40

5.09

6.25

GPM (%)

5.35

-10.65

7.66

4.50

8.64

NPM (%)

0.88

-7.53

18.52

-0.24

2.10